JUN 16, 2020 10:06 AM PDT

Wearable patch for melanoma patients

Research published in the journal ACS Nano describes a wearable patch that can be used to lessen side effects from chemotherapy and radiotherapy for melanoma patients. The innovation was created by researchers at Purdue University in response to the suffering that melanoma patients undergo when receiving conventional therapies to fight the cancer. 

Melanoma is an aggressive kind of skin cancer that can metastasize quickly if it is not treated early. Additionally, it is a particularly tricky cancer because melanoma cells are known for being recurrent in their nature.

"We developed a novel wearable patch with fully miniaturized needles, enabling unobtrusive drug delivery through the skin for the management of skin cancers," said Chi Hwan Lee, who is a Purdue assistant professor of biomedical engineering and mechanical engineering. "Uniquely, this patch is fully dissolvable by body fluids in a programmable manner such that the patch substrate is dissolved within one minute after the introduction of needles into the skin, followed by the gradual dissolution of the silicon needles inside the tissues within several months."

The bioresorbable silicon nanoneedles are constructed on a thin, flexible and water-soluble medical film which is used to insert the needles. The silicon nanoneedles dissolve quickly into the skin afterward but because they stay active over time, the patch provides delivery of anti-cancer drugs for  an extended period. Eventually, the biocompatible nanoneedles dissolve in into tissue fluids and reabsorb into the body without any adverse secondary effects. 

"The uniqueness of our technology arises from the fact that we used extremely small but long-lasting silicon nanoneedles with sharpened angular tips that are easy for their penetration into the skin in a painless and minimally invasive manner," Lee said.

The patch will provide more comfort to melanoma patients than conventional treatment options. Photo: Pixabay

Compared to conventional microneedles, the nanoneedles’ pore surface areas are able to provide a large drug loading capacity, which Lee says can target melanoma sites to deliver chemotherapeutic drugs. 

Following Eureka Alert, Lee said he got inspired to create such an innovation after observing how scared his daughter was of needles when receiving vaccinations.

Sources: ACS Nano, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 16, 2020
Cancer
I'm addicted to the sun, are you?
SEP 16, 2020
I'm addicted to the sun, are you?
New research published in the Journal of Investigative Dermatology reports evidence that some people are geneticall ...
SEP 21, 2020
Cancer
Black women have delayed and longer breast cancer treatment
SEP 21, 2020
Black women have delayed and longer breast cancer treatment
A study led by UNC Lineberger Comprehensive Cancer Center researchers has quantified the healthcare inequities in cancer ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
NOV 27, 2020
Cell & Molecular Biology
UVC Rays May be a Bigger Cancer Risk Than Known
NOV 27, 2020
UVC Rays May be a Bigger Cancer Risk Than Known
The sun emits different kinds of light and rays including visible and ultraviolet (UV) and infrared. Some of those forms ...
DEC 02, 2020
Immunology
A Shingles Vaccine for Cancer Patients
DEC 02, 2020
A Shingles Vaccine for Cancer Patients
Receiving a vaccine (usually in the form of an inactivated pathogen) triggers an immune response without the symptoms of ...
Loading Comments...